Personal information

Other IDs

Scopus Author ID: 7006224629
SciProfiles: 2496039

Keywords

Pharmacology

Countries

Czech Republic

Activities

Collapse all

Employment (1)

Palacký University, Olomouc: Olomouc, CZ

1994-10-01 to present (Faculty of Medicine and Dentistry)
Employment
Source: Self-asserted source
Karel Urbánek

Education and qualifications (1)

Palacký University, Olomouc: Olomouc, CZ

1988 to 1994 | MUDr. (Faculty of Medicine and Dentistry)
Education
Source: Self-asserted source
Karel Urbánek

Works (50 of 137)

Items per page:
Page 1 of 3

Challenges of Colistin Use in ICU and Therapeutic Drug Monitoring: A Literature Review

Antibiotics
2023-02 | Journal article | Author
DOI: 10.3390/antibiotics12030437
Contributors: Jitka Rychlickova; Vendula Kubíčková; Pavel Suk; Karel Urbánek
Source: check_circle
Multidisciplinary Digital Publishing Institute

Population Pharmacokinetics of Prophylactic Cefazolin in Cardiac Surgery with Standard and Minimally Invasive Extracorporeal Circulation

Antibiotics
2022-11 | Journal article | Author
DOI: 10.3390/antibiotics11111582
Contributors: Petr Šantavý; Martin Šíma; Ondřej Zuščich; Vendula Kubíčková; Danica Michaličková; Ondřej Slanař; Karel Urbánek
Source: check_circle
Multidisciplinary Digital Publishing Institute

Acid-based disturbances due to perioperative fluid therapy with slightly alkalized and acid-based neutral balanced crystalloids: A comparative study

Signa Vitae
2017 | Journal article
DOI: 10.22514/SV131.032017.16
Source: Self-asserted source
Karel Urbánek

Infliximab [Infliximab]

Interni Medicina pro Praxi
2017 | Journal article
Source: Self-asserted source
Karel Urbánek

Infliximab | Infliximab

Interni Medicina pro Praxi
2017 | Journal article
EID:

2-s2.0-85016501274
Contributors: Urbánek, K.
Source: Self-asserted source
Karel Urbánek via Scopus - Elsevier

Is continuous infusion of imipenem always the best choice?

International Journal of Antimicrobial Agents
2017 | Journal article
DOI: 10.1016/j.ijantimicag.2016.12.005
Source: Self-asserted source
Karel Urbánek

Possible interaction between mycophenolate mofetil and tacrolimus in kidney transplant patients [Interakce mezi mykofenolát mofetilem a takrolimem u pacientů po transplantaci ledviny]

Klinicka Farmakologie a Farmacie
2017 | Journal article
Source: Self-asserted source
Karel Urbánek

Possible interaction between mycophenolate mofetil and tacrolimus in kidney transplant patients | Interakce mezi mykofenolát mofetilem a takrolimem u pacientů po transplantaci ledviny

Klinicka Farmakologie a Farmacie
2017 | Journal article
EID:

2-s2.0-85037368091
Contributors: Strojil, J.; Orság, J.; Fürst, T.; Urbánek, K.; Anzenbacher, P.; Krejčí, K.
Source: Self-asserted source
Karel Urbánek via Scopus - Elsevier

Rivaroxaban – pharmacological profile [Rivaroxaban – farmakologický profil]

Kardiologicka Revue
2017 | Journal article
Source: Self-asserted source
Karel Urbánek

Rivaroxaban – pharmacological profile | Rivaroxaban – farmakologický profil

Kardiologicka Revue
2017 | Journal article
EID:

2-s2.0-85016561378
Contributors: Urbánek, K.
Source: Self-asserted source
Karel Urbánek via Scopus - Elsevier

Antibiotic therapy of hospital-acquired pneumonia and its pharmacoeconomics [Antibiotická léčba nozokomiálních pneumonií a její farmakoekonomika]

Klinicka Mikrobiologie a Infekcni Lekarstvi
2016 | Journal article
Source: Self-asserted source
Karel Urbánek

Antibiotic therapy of hospital-acquired pneumonia and its pharmacoeconomics | Antibiotická léčba nozokomiálních pneumonií a její farmakoekonomika

Klinicka Mikrobiologie a Infekcni Lekarstvi
2016 | Journal article
EID:

2-s2.0-84974556075
Contributors: Kolář, M.; Sedláková, M.H.; Urbánek, K.; Uvízu, R.; Adamus, M.; Imwensi, O.P.
Source: Self-asserted source
Karel Urbánek via Scopus - Elsevier

Residual volumes and final weights in different types of plastic infusion containers

International Journal of Pharmacy and Pharmaceutical Sciences
2016 | Journal article
Source: Self-asserted source
Karel Urbánek

Residual volumes and final weights in different types of plastic infusion containers

International Journal of Pharmacy and Pharmaceutical Sciences
2016 | Journal article
EID:

2-s2.0-84960107714
Contributors: Štrbová, P.; Šiller, M.; Urbánek, K.; Poruba, M.
Source: Self-asserted source
Karel Urbánek via Scopus - Elsevier

Specific features of pharmacokinetics in children

Drug Metabolism Reviews
2016 | Journal article
DOI: 10.3109/03602532.2015.1135941
Source: Self-asserted source
Karel Urbánek

Acute pancreatitis as the first manifestation of duodenal MALT lymphoma

Biomedical Papers
2015 | Journal article
DOI: 10.5507/bp.2015.047
Source: Self-asserted source
Karel Urbánek

Analysis of arterial hypertension pharmacotherapy in patients with obstructive sleep apnea syndrome

Cor et Vasa
2015 | Journal article
DOI: 10.1016/j.crvasa.2015.03.011
Source: Self-asserted source
Karel Urbánek

Direct oral anticoagulants - perspectives of therapeutic drug monitoring [Pšémé perorélné antikoagulancia - Perspektivy terapeutického monitorování]

Kardiologicka Revue
2015 | Journal article
Source: Self-asserted source
Karel Urbánek

Direct oral anticoagulants - perspectives of therapeutic drug monitoring | Pšémé perorélné antikoagulancia - Perspektivy terapeutického monitorování

Kardiologicka Revue
2015 | Journal article
EID:

2-s2.0-84926383563
Contributors: Urbánek, K.
Source: Self-asserted source
Karel Urbánek via Scopus - Elsevier

Foreword [Slovo úvodem]

Klinicka Farmakologie a Farmacie
2015 | Journal article
Source: Self-asserted source
Karel Urbánek

Foreword | Slovo úvodem

Klinicka Farmakologie a Farmacie
2015 | Journal article
EID:

2-s2.0-84961257421
Contributors: Urbánek, K.
Source: Self-asserted source
Karel Urbánek via Scopus - Elsevier

Úvodní slovo

Klinicka Farmakologie a Farmacie
2015 | Journal article
EID:

2-s2.0-84958568556
Contributors: Urbánek, K.
Source: Self-asserted source
Karel Urbánek via Scopus - Elsevier

Adverse Drug Reactions Causing Hospital Admissions in Childhood: A Prospective, Observational, Single-Centre Study

Basic and Clinical Pharmacology and Toxicology
2014 | Journal article
DOI: 10.1111/bcpt.12264
Source: Self-asserted source
Karel Urbánek

Antibiotic consumption and its influence on the resistance in Enterobacteriaceae

BMC Research Notes
2014 | Journal article
DOI: 10.1186/1756-0500-7-454
Source: Self-asserted source
Karel Urbánek

Effect of the infusion system on the quality of parenteral treatment [Vliv infuzního systému na kvalitu parenterální léčby]

Klinicka Farmakologie a Farmacie
2014 | Journal article
Source: Self-asserted source
Karel Urbánek

Effect of the infusion system on the quality of parenteral treatment | Vliv infuzního systému na kvalitu parenterální léčby

Klinicka Farmakologie a Farmacie
2014 | Journal article
EID:

2-s2.0-84897549613
Contributors: Urbánek, K.; Poruba, M.; Štrbová, P.
Source: Self-asserted source
Karel Urbánek via Scopus - Elsevier

First biosimilar monoclonal antibody introduced to clinical praxis: Infliximab [První biosimilární monoklonální protilátka - Infliximab]

Klinicka Farmakologie a Farmacie
2014 | Journal article
Source: Self-asserted source
Karel Urbánek

First biosimilar monoclonal antibody introduced to clinical praxis: Infliximab | První biosimilární monoklonální protilátka - Infliximab

Klinicka Farmakologie a Farmacie
2014 | Journal article
EID:

2-s2.0-84897532848
Contributors: Urbánek, K.
Source: Self-asserted source
Karel Urbánek via Scopus - Elsevier

Incidence of unlicensed and off-label prescription in children

Italian Journal of Pediatrics
2014 | Journal article
DOI: 10.1186/1824-7288-40-12
Source: Self-asserted source
Karel Urbánek

Irritable bowel syndrome - Diagnosis and Treatment [Dráždivý tračník - Diagnostika a léčba]

Kardiologicka Revue
2014 | Journal article
Source: Self-asserted source
Karel Urbánek

Irritable bowel syndrome - Diagnosis and Treatment | Dráždivý tračník - Diagnostika a léčba

Kardiologicka Revue
2014 | Journal article
EID:

2-s2.0-84904612422
Contributors: Ehrmann, J.; Urbánek, K.
Source: Self-asserted source
Karel Urbánek via Scopus - Elsevier

Pharmacokinetics of imipenem in critically ill patients during empirical treatment of nosocomial pneumonia: A comparison of 0.5-h and 3-h infusions

International Journal of Antimicrobial Agents
2014 | Journal article
DOI: 10.1016/j.ijantimicag.2014.05.011
Source: Self-asserted source
Karel Urbánek
grade
Preferred source (of 3)‎

Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients

Biomedical Papers
2014 | Journal article
DOI: 10.5507/bp.2012.092
Source: Self-asserted source
Karel Urbánek
grade
Preferred source (of 3)‎

Effect of colistin consumption and prevalence of colistin-resistant bacteria [Vliv spotřeby kolistinu na výskyt kolistin- rezistentních bakterií]

Klinicka Mikrobiologie a Infekcni Lekarstvi
2013 | Journal article
Source: Self-asserted source
Karel Urbánek

Effect of colistin consumption and prevalence of colistin-resistant bacteria [Vliv spotřeby kolistinu na výskyt kolistin- rezistentních bakterií]

Klinicka Mikrobiologie a Infekcni Lekarstvi
2013 | Journal article
Source: Self-asserted source
Karel Urbánek

Effect of colistin consumption and prevalence of colistin-resistant bacteria [Vliv spotřeby kolistinu na výskyt kolistin- rezistentních bakterií]

Klinicka Mikrobiologie a Infekcni Lekarstvi
2013 | Journal article
Source: Self-asserted source
Karel Urbánek

Effect of colistin consumption and prevalence of colistin-resistant bacteria | Vliv spotřeby kolistinu na výskyt kolistin- rezistentních bakterií

Klinicka Mikrobiologie a Infekcni Lekarstvi
2013 | Journal article
EID:

2-s2.0-84881415106
Contributors: Hanulík, V.; Suchánková, H.; Urbánek, K.; Imwensi, P.; Htoutou Sedláková, M.; Vojtová, V.; Kolář, M.
Source: Self-asserted source
Karel Urbánek via Scopus - Elsevier

Fenofibrate and its pharmaceutical formulations [Fenofibrát a jeho lékové formy]

Interni Medicina pro Praxi
2013 | Journal article
Source: Self-asserted source
Karel Urbánek

Fenofibrate and its pharmaceutical formulations [Fenofibrát a jeho lékové formy]

Interni Medicina pro Praxi
2013 | Journal article
Source: Self-asserted source
Karel Urbánek

Fenofibrate and its pharmaceutical formulations [Fenofibrát a jeho lékové formy]

Interni Medicina pro Praxi
2013 | Journal article
Source: Self-asserted source
Karel Urbánek

Fenofibrate and its pharmaceutical formulations | Fenofibrát a jeho lékové formy

Interni Medicina pro Praxi
2013 | Journal article
EID:

2-s2.0-84874841193
Contributors: Gajdová, J.; Urbánek, K.
Source: Self-asserted source
Karel Urbánek via Scopus - Elsevier

Incidence of potential drug interactions in medication prescriptions for children and adolescents in the University Hospital Olomouc, Czech Republic

European Journal of Pediatrics
2013 | Journal article
DOI: 10.1007/s00431-013-1933-7
Source: Self-asserted source
Karel Urbánek
grade
Preferred source (of 3)‎

Pharmacological characteristics of ertapenem [Farmakologické vlastnosti ertapenemu]

Klinicka Mikrobiologie a Infekcni Lekarstvi
2013 | Journal article
Source: Self-asserted source
Karel Urbánek

Pharmacological characteristics of ertapenem [Farmakologické vlastnosti ertapenemu]

Klinicka Mikrobiologie a Infekcni Lekarstvi
2013 | Journal article
Source: Self-asserted source
Karel Urbánek

Pharmacological characteristics of ertapenem [Farmakologické vlastnosti ertapenemu]

Klinicka Mikrobiologie a Infekcni Lekarstvi
2013 | Journal article
Source: Self-asserted source
Karel Urbánek

Pharmacological characteristics of ertapenem | Farmakologické vlastnosti ertapenemu

Klinicka Mikrobiologie a Infekcni Lekarstvi
2013 | Journal article
EID:

2-s2.0-84878751214
Contributors: Urbánek, K.; Suchánková, H.
Source: Self-asserted source
Karel Urbánek via Scopus - Elsevier

Drug-induced cholestatic liver injury

Bilirubin: Chemistry, Regulation and Disorder
2012 | Book
Source: Self-asserted source
Karel Urbánek

Drug-induced cholestatic liver injury

Bilirubin: Chemistry, Regulation and Disorder
2012 | Book
EID:

2-s2.0-84891994691
Contributors: Urbánek, K.; Krystynísk, O.; Procházka, V.
Source: Self-asserted source
Karel Urbánek via Scopus - Elsevier

Drug-induced cholestatic liver injury

Bilirubin: Chemistry, Regulation and Disorder
2012 | Book
Source: Self-asserted source
Karel Urbánek

Drug-induced cholestatic liver injury

Bilirubin: Chemistry, Regulation and Disorder
2012 | Book
Source: Self-asserted source
Karel Urbánek
Items per page:
Page 1 of 3
How many people are using ORCID?